Multinational Pharmaceutical Company Cybersecurity Transformation

This case study outlines the challenges faced by a multinational pharmaceutical company in its cybersecurity program, particularly regarding visibility of its attack surface, asset discovery, and vulnerability prioritization. The company lacked effective procedures for identifying assets and measuring success through benchmarking and metrics. DeepSeas provided professional services to formalize processes for conducting vulnerability assessments, enhancing collaboration across security functions and business units. The implementation included tracking remediation efforts and escalating overdue tasks while reporting key performance metrics to IT leadership. The integration of DeepSeas' vulnerability management and attack surface reduction services with other professional services offered significant benefits. Regular communication with cyber threat intelligence experts enabled the identification of relevant threats, while collaboration with threat detection operations tested security controls. The case study emphasizes the importance of integrating these services to enhance organizational collaboration and maximize investment in cybersecurity initiatives.